Active, not recruitingPhase 2NCT04908735

Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Kasiani Myers, MD
Children's Hospital Medical Center, Cincinnati
Intervention
Ruxolitinib(drug)
Enrollment
7 enrolled
Eligibility
5-60 years · All sexes
Timeline
20212028

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04908735 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials